PRISM FOR PTSD
Prism for PTSD is an evidence-based, prescription therapy, FDA-cleared to treat PTSD. During Prism treatment, a computer simulation and EEG headset create an environment where patients engage in a non-trauma-based experience to help them learn to control their PTSD symptoms.
​
Prism is the first PTSD treatment based on a digital brain-mechanism-specific biomarker associated with mental health disorders. Read more about the technology behind Prism for PTSD.
PRISM REGIMEN
15 sessions, over 8 weeks or
as determined by healthcare provider.
Booster sessions as needed.
Each session lasts about 45 minutes.
PROVEN CLINICAL OUTCOMES
Clinical studies have demonstrated durable improvement in PTSD symptoms with a high safety profile.
OPERATIONAL SIMPLICITY
With installation and training taking four hours, team can be trained in the morning and treating patients the same afternoon.
REDUCED COSTS
Prism can be operated by a non-MD healthcare professional, such as an NP, social worker or technician.
ENGAGED PATIENT EXPERIENCE
Personalized, non-trauma based treatment that helps patients gain a sense of control over their PTSD symptoms, and their lives.
The Prism for PTSD multi-center clinical study demonstrated the following results
3 months after the 15-session regimen (5 months from baseline):
​
-
67% of patients overall demonstrated clinically significant symptom improvement
as measured by CAPS-5. -
Significant improvement in sleep, as measured by PHQ-9 and CAPS-5.
-
32% of patients experienced remission.
-
90% patient compliance.
-
Mild side effects, such as fatigue and headache, resolved after treatment
with no further intervention.